Parco Pharmaceuticals Private Limited - Company Profile

It is a plastics private limited company based in Pune City, Maharashtra, India, established in 1984.
1984 Pune City, Maharashtra, India Active
Last Updated:
About Parco Pharmaceuticals Private Limited

Parco Pharmaceuticals Private Limited, a active private limited company, was established on 01 August 1984 in Pune City, Maharashtra, India. Engaging in fabricated metal products within the manufacturing sector, it holds CIN: U24239PN1984PTC033640. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.85 M.

It upholds a compliant status. Its leadership includes Vandana Vijaykumar Inamdar (Director), Shardul Amit Inamdar (Director), Amit Vijaykumar Inamdar (Additional Director). Past directors included Niranjan Vijaykumar Inamdar, Vandana Vijaykumar Inamdar, Shardul Amit Inamdar. It holds no open charges and ₹1.37 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Flat No.402, , Lotus Residency, Cts No.681, S.No.15/12, Plot No.5, Sangam Press Road, Kothrud, Pune City, Maharashtra, 411038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239PN1984PTC033640

  • Registration Number

    033640

  • Incorporation Date

    01 August 1984

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.85 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.85 M
  • Company Age 41 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Satisfied Charges ₹ 1.37 M
Company report

Parco Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Parco Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Parco Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Vandana Vijaykumar Inamdar Director 16 Jul 2024 Current
Shardul Amit Inamdar Director 24 Jul 2024 Current
Amit Vijaykumar Inamdar Additional Director 30 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Director 21 Nov 2024 Past
Pramod Abcsdd Director 01 Oct 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Parco Pharmaceuticals.

Parco Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Parco Pharmaceuticals revenue growth over time
Parco Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Parco Pharmaceuticals?

In 2017, Parco Pharmaceuticals had a promoter holding of 53.08% and a public holding of 46.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹1,365,000.00

Charges Breakdown by Lending Institutions
  • The United Western Bank Ltd : 0.11 Cr
  • The Sangli Bank Ltd. : 0.03 Cr
Latest Charge Details
Date Lender Amount Status
29 Oct 1994 The United Western Bank Ltd ₹0.42 M Satisfied
12 Oct 1994 The United Western Bank Ltd ₹0.65 M Satisfied
24 Apr 1991 The Sangli Bank Ltd. ₹0.15 M Satisfied
23 Jul 1990 The Sangli Bank Ltd. ₹0.15 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Parco Pharmaceuticals?

Unlock and access historical data on people associated with Parco Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Parco Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parco Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Parco Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Parco Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Parco Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.

  • Director Appointment

    The activity Amit Vijaykumar Inamdar was appointed as a Additional Director was appointed as a Additional Director on 30 Mar 2025 & has been associated with this company since 10 months 18 days . was completed.

  • Director Appointment

    The activity Shardul Amit Inamdar was appointed as a Director was appointed as a Director on 24 Jul 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Director Appointment

    Progress on Vandana Vijaykumar Inamdar was appointed as a Director was appointed as a Director on 16 Jul 2024 & has been associated with this company since 1 year 7 months . was documented.

  • Charges

    A charge registered on 24 Apr 1991 via Charge ID 90083752 with The Sangli Bank Ltd. was fully satisfied on 26 Jun 2012. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Parco Pharmaceuticals Private Limited?

The CIN of Parco Pharmaceuticals Private Limited is U24239PN1984PTC033640.

Where is Parco Pharmaceuticals Private Limited headquartered?

Parco Pharmaceuticals Private Limited is headquartered at Flat No.402, , Lotus Residency, Cts No.681, S.No.15/12, Plot No.5, Sangam Press Road, Kothrud, Pune City, Maharashtra, 411038.

When was Parco Pharmaceuticals Private Limited incorporated?

Parco Pharmaceuticals Private Limited was incorporated on 01 August 1984.

Who are the current directors of Parco Pharmaceuticals Private Limited?

The current directors of Parco Pharmaceuticals Private Limited are

What is the primary industry of Parco Pharmaceuticals Private Limited?

The primary industry of Parco Pharmaceuticals Private Limited is Manufacturing.

Is Parco Pharmaceuticals Private Limited a listed company?

Parco Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Parco Pharmaceuticals Private Limited?

The authorized capital of Parco Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.85 M.

What is the compliance status of Parco Pharmaceuticals Private Limited?

The compliance status of Parco Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available